Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 14, 2018 - Issue 7
Submit an article Journal homepage
2,185
Views
10
CrossRef citations to date
0
Altmetric
Commentary

Funding vaccines for emerging infectious diseases

Gary WongGuangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious Diseases, Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People's Hospital, Shenzhen, ChinaView further author information
&
Xiangguo QiuSpecial Pathogens Program, National Microbiology Laboratory, Winnipeg, Canada;Department of Medical Microbiology, University of Manitoba, Winnipeg, CanadaCorrespondence[email protected]
View further author information
Pages 1760-1762 | Received 01 Nov 2017, Accepted 24 Nov 2017, Published online: 16 Jan 2018

References

  • CEPI.net. CEPI's end-to-end gap-filling role: a sustainable partnership approach. 2017. http://cepi.net/sites/default/files/CEPI_Gap_Filling_Role.pdf.
  • Pronker ES, Weenen TC, Commandeur HR, Osterhaus AD, Claassen HJ. The gold industry standard for risk and cost of drug and vaccine development revisited. Vaccine. 2011;29:5846–9. doi:10.1016/j.vaccine.2011.06.051.
  • Rottingen JA, Gouglas D, Feinberg M, Plotkin S, Raghavan KV, Witty A, Draghia-Akli R, Stoffels P, Piot P. New Vaccines against Epidemic Infectious Diseases. New England journal of medicine. 2017;376:610–3. doi:10.1056/NEJMp1613577.
  • Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang ZY, Roederer M, Koup RA, Jahrling PB, Nabel GJ. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature. 2003;424:681–4. doi:10.1038/nature01876.
  • Jones SM, Feldmann H, Stroher U, Geisbert JB, Fernando L, Grolla A, Klenk HD, Sullivan NJ, Volchkov VE, Fritz EA, et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nature medicine. 2005;11:786–90. doi:10.1038/nm1258.
  • Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, et al. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine. 2010;29:304–13. doi:10.1016/j.vaccine.2010.10.037.
  • Plotkin SA, Mahmoud AA, Farrar J. Establishing a Global Vaccine-Development Fund. New England journal of medicine. 2015;373:297–300. doi:10.1056/NEJMp1506820.
  • CEPI.net. CEPI – Approach. 2017. http://cepi.net/approach.
  • WHO.int. List of Blueprint priority diseases. 2017. http://www.who.int/blueprint/priority-diseases/en/.
  • Global Consortium for HN, Related Influenza V. Role for migratory wild birds in the global spread of avian influenza H5N8. Science. 2016; 354:213–7. doi:10.1126/science.aaf8852.
  • Bi Y, Chen Q, Wang Q, Chen J, Jin T, Wong G, Quan C, Liu J, Wu J, Yin R, et al. Genesis, Evolution and Prevalence of H5N6 Avian Influenza Viruses in China. Cell host & microbe. 2016;20:810–21. doi:10.1016/j.chom.2016.10.022.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.